An open-label phase 2 study treating patients with first or second relapse of multiple myeloma with carfilzomib, pomalidomide, and dexamethasone (KPd): SELECT study.
Saved in:
| Title: | An open-label phase 2 study treating patients with first or second relapse of multiple myeloma with carfilzomib, pomalidomide, and dexamethasone (KPd): SELECT study. |
|---|---|
| Authors: | Perrot, Aurore1 (AUTHOR), Delimpasi, Sosana2 (AUTHOR), Spanoudakis, Emmanouil3 (AUTHOR), Frølund, Ulf4 (AUTHOR), Belotti, Angelo5 (AUTHOR), Oriol, Albert6 (AUTHOR), Moreau, Philippe7 (AUTHOR), McFadden, Ian8 (AUTHOR), Xia, Qing8 (AUTHOR), Arora, Mukta8 (AUTHOR), Dimopoulos, Meletios Athanasios9 (AUTHOR) mdimop@med.uoa.gr |
| Source: | Leukemia & Lymphoma. Jun2024, Vol. 65 Issue 6, p833-842. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
